Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Long-Term Safety of Fenofibric Acid and Statin Combination in Mixed Dyslipidemia
NCT00300430Phase 3Completed
- Sponsor
- Abbott Laboratories
- Start
- Sep 2006
- Primary completion
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of fenofibric acid in mixed dyslipidemia (3 arms), sponsored by Abbott Laboratories. Primary endpoint: Percentage of Subjects Reporting Adverse Events During Combination Therapy. Started Sep 2006; status: completed.
02
Drugs
fenofibric acid
03
Conditions
mixed dyslipidemia
Beyond the preview
Go deeper on NCT00300430.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00300430.